These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

904 related articles for article (PubMed ID: 16196488)

  • 1. Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs. 1. In vitro evaluations.
    Shenoy D; Little S; Langer R; Amiji M
    Mol Pharm; 2005; 2(5):357-66. PubMed ID: 16196488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and characterization of polymeric pH-sensitive STEALTH® nanoparticles for tumor delivery of a lipophilic prodrug of paclitaxel.
    Lundberg BB
    Int J Pharm; 2011 Apr; 408(1-2):208-12. PubMed ID: 21296135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: part 3. Therapeutic efficacy and safety studies in ovarian cancer xenograft model.
    Devalapally H; Shenoy D; Little S; Langer R; Amiji M
    Cancer Chemother Pharmacol; 2007 Mar; 59(4):477-84. PubMed ID: 16862429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: part 2. In vivo distribution and tumor localization studies.
    Shenoy D; Little S; Langer R; Amiji M
    Pharm Res; 2005 Dec; 22(12):2107-14. PubMed ID: 16254763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive biodegradable system for paclitaxel delivery.
    Potineni A; Lynn DM; Langer R; Amiji MM
    J Control Release; 2003 Jan; 86(2-3):223-34. PubMed ID: 12526819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(ethylene oxide)-modified poly(epsilon-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer.
    Shenoy DB; Amiji MM
    Int J Pharm; 2005 Apr; 293(1-2):261-70. PubMed ID: 15778064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery.
    Zhang L; Zhu D; Dong X; Sun H; Song C; Wang C; Kong D
    Int J Nanomedicine; 2015; 10():2101-14. PubMed ID: 25844039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paclitaxel-loaded SCK nanoparticles: an investigation of loading capacity and cell killing abilities in vitro.
    Lin LY; Karwa A; Kostelc JG; Lee NS; Dorshow RB; Wooley KL
    Mol Pharm; 2012 Aug; 9(8):2248-55. PubMed ID: 22742525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel self-associating poly(ethylene oxide)-b-poly(epsilon-caprolactone) based drug conjugates and nano-containers for paclitaxel delivery.
    Shahin M; Lavasanifar A
    Int J Pharm; 2010 Apr; 389(1-2):213-22. PubMed ID: 20080163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles.
    Zhang Z; Feng SS
    Biomaterials; 2006 Jul; 27(21):4025-33. PubMed ID: 16564085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphiphilic methoxy poly(ethylene glycol)-b-poly(ε-caprolactone)-b-poly(2-dimethylaminoethyl methacrylate) cationic copolymer nanoparticles as a vector for gene and drug delivery.
    Yue X; Qiao Y; Qiao N; Guo S; Xing J; Deng L; Xu J; Dong A
    Biomacromolecules; 2010 Sep; 11(9):2306-12. PubMed ID: 20666510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Toxicity of Doxorubicin Encapsulated into pH-Responsive Poly(β-Amino Ester)-Functionalized MCM-41 Silica Nanoparticles.
    Ávila-Ortega A; Carrillo-Cocom LM; Olán-Noverola CE; Nic-Can GI; Vilchis-Nestor AR; Talavera-Pech WA
    Curr Drug Deliv; 2020; 17(9):799-805. PubMed ID: 32723272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticles of poly(lactide)/vitamin E TPGS copolymer for cancer chemotherapy: synthesis, formulation, characterization and in vitro drug release.
    Zhang Z; Feng SS
    Biomaterials; 2006 Jan; 27(2):262-70. PubMed ID: 16024075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
    He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
    Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and application of poly(ethylene glycol)-co-poly(β-amino ester) copolymers for small cell lung cancer gene therapy.
    Kim J; Kang Y; Tzeng SY; Green JJ
    Acta Biomater; 2016 Sep; 41():293-301. PubMed ID: 27262740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Fluorouracil-loaded PLA/PLGA PEG-PPG-PEG polymeric nanoparticles: formulation, in vitro characterization and cell culture studies.
    Ocal H; Arica-Yegin B; Vural I; Goracinova K; Caliş S
    Drug Dev Ind Pharm; 2014 Apr; 40(4):560-7. PubMed ID: 23596973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel paclitaxel-loaded poly(epsilon-caprolactone)/Poloxamer 188 blend nanoparticle overcoming multidrug resistance for cancer treatment.
    Zhang Y; Tang L; Sun L; Bao J; Song C; Huang L; Liu K; Tian Y; Tian G; Li Z; Sun H; Mei L
    Acta Biomater; 2010 Jun; 6(6):2045-52. PubMed ID: 19969111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paclitaxel molecularly imprinted polymer-PEG-folate nanoparticles for targeting anticancer delivery: Characterization and cellular cytotoxicity.
    Esfandyari-Manesh M; Darvishi B; Ishkuh FA; Shahmoradi E; Mohammadi A; Javanbakht M; Dinarvand R; Atyabi F
    Mater Sci Eng C Mater Biol Appl; 2016 May; 62():626-33. PubMed ID: 26952466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticles of poly(D,L-lactide)/methoxy poly(ethylene glycol)-poly(D,L-lactide) blends for controlled release of paclitaxel.
    Dong Y; Feng SS
    J Biomed Mater Res A; 2006 Jul; 78(1):12-9. PubMed ID: 16596586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of novel biodegradable nanoparticles for the drug targeting to breast cancer cells.
    Mattu C; Pabari RM; Boffito M; Sartori S; Ciardelli G; Ramtoola Z
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):463-72. PubMed ID: 23916461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.